Anthem Biosciences

Anthem Biosciences

Bangalore, India· Est.

An integrated Indian CRDMO offering end-to-end development and manufacturing services for small molecules, peptides, and biologics.

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

AI Company Overview

An integrated Indian CRDMO offering end-to-end development and manufacturing services for small molecules, peptides, and biologics.

Technology Platform

Integrated CRDMO platform combining advanced synthetic chemistry (biocatalysis, flow chemistry, micellar chemistry) for small molecules with microbial and mammalian cell culture platforms for biologics development and manufacturing.

Opportunities

Growth is driven by expanding capacity (Unit IV), increasing demand for complex modality manufacturing (peptides, oligos, HPAPIs), and capturing more late-stage and commercial supply contracts from global biopharma clients.

Risk Factors

Key risks include regulatory compliance challenges across rapidly expanding facilities, intense pricing and capability competition in the global CDMO market, and potential reliance on a limited number of large client programs.

Competitive Landscape

Competes with Indian CRDMOs like Syngene and Jubilant, and global CDMOs like Lonza. Differentiates through a fully integrated, end-to-end service model, a strong track record in regulatory inspections, and expertise in both complex chemistry and biologics.